Pages Menu
FacebookTwitterPinterestRss
Categories Menu

Posted by on Feb 20, 2017 in Foundation NewsLine, Type C |

CTD Holdings Update

CTD Holdings Presents Compassionate Use Data
on Trappsol(R) Cyclo(TM) to Treat
Niemann-Pick Disease Type C and Provides Update
on Progress of U.S. and EU Clinical Trials at
13th Annual WORLDSymposium

CLICK HERE FOR COMPLETE ANNOUNCEMENT

Share this!

Please spread the word!

FACEBOOK
TWITTER
PINTEREST